ThursdayJan 12, 2023 11:15 am

TinyGemsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Moves to Acquire MeridianBet Group

Golden Matrix Group (NASDAQ: GMGI) is a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content. The company today announced its entry into a definitive acquisition agreement pursuant to which it has agreed to acquire MeridianBet Group and its related companies in a cash and stock transaction valued at approximately $300 million. MeridianBet is Southeast Europe’s leading business-to-consumer (“B2C”) sports betting and gaming group with headquarters in Malta, operating in multiple markets across Europe, Africa and Latin America. “We are thrilled to announce our entry into a purchase agreement with the shareholders of MeridianBet…

Continue Reading

ThursdayJan 12, 2023 10:34 am

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Selects Generalized Anxiety Disorder as Target Indication for CYB004

Cybin (NYSE American: CYBN) (NEO: CYBN) is a biotechnology company focused on progressing Psychedelics to Therapeutics(R). The company today announced that it has selected Generalized Anxiety Disorder (“GAD”) with or without major depressive disorder (“MDD”) as the target indication for CYB004 — its proprietary deuterated N, N-dimethyltryptamine (“DMT”) molecule. “Based on preclinical data, CYB004 has shown promise in treating anxiety disorders. About half of people suffering from depression are also burdened with GAD, which makes the need for more effective treatment options for GAD even more urgent,” said Cybin CEO Doug Drysdale. “Since the pandemic, the prevalence of depression and…

Continue Reading

ThursdayJan 12, 2023 10:14 am

TinyGemsBreaks — Cepton Inc. (NASDAQ: CPTN) Announces Approval of Preferred Stock Issue by Shareholders

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, reported that its stockholders approved the company’s proposal to issue 100,000 shares of Series A Convertible Preferred Stock to Koito Manufacturing Co. Ltd.  The issuance, which would be for $100 million, is based on the terms of an investment agreement between the two companies that was signed on Oct. 27, 2022. According to the announcement, the investment should close on Jan. 19, 2023. Shareholders voted on the proposal during Cepton’s recent special meeting of shareholders, which was held on Jan. 11, 2023. To view the full press release,…

Continue Reading

TuesdayJan 10, 2023 12:26 pm

TinyGemsBreaks – Vision Energy Corp. (VENG) Incorporates Dutch Subsidiaries

Vision Energy (OTCQB: VENG), a forward-looking energy company developing carbon reduced solutions for the commercial, industrial and transportation sector, has incorporated new Dutch subsidiaries. These incorporations are designed to accommodate strategic initiatives for prospective partners, operators and launching customers for VENG’s integrated Green Energy Hub development in North Sea Port of Vlissingen, the Netherlands. According to the announcement, Vision Energy incorporated Vision Hydrogen BV as a project development company to develop, own and operate its planned Ammonia Cracking Facility. The facility will be used for back-cracking imported green ammonia to hydrogen gas as a service and will be combined with the…

Continue Reading

TuesdayJan 10, 2023 11:47 am

TinyGemsBreaks – QSAM Biosciences Inc. (QSAM) Releases Shareholder Letter Outlining 2022 Updates, 2023 Milestone Goals

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases, has provided key updates and milestone goals in a shareholder letter; the letter is from QSAM Biosciences executive chair and cofounder C. Richard Piazza and CEO and cofounder Douglas Baum. The letter noted that QSAM is developing its lead therapeutic radiopharmaceutical drug candidate, CycloSam, to treat cancer that has either originated in the bone or has metastasized to the bone from the breast, prostate, lung or other organs. During 2022, CycloSam received rare pediatric disease designation for the…

Continue Reading

TuesdayJan 10, 2023 11:35 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestones, 2023 Business Outlook

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today outlined key accomplishments from 2022 and provided a business update and catalysts for 2023. “Over the course of 2022, we strengthened our position as a leader in rare cannabinoid R&D, creating a unique offering as the only company that has the breadth and depth in cannabinoid drug research, development and significant manufacturing know-how,” said Eric A. Adams, InMed president and CEO. “Despite the many economic pressures affecting businesses on a global scale, including challenging capital markets, particularly in biotech, InMed…

Continue Reading

MondayJan 09, 2023 2:13 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Kicks Off New Year with Multiple New Contracts, Announces Planned Path to Profitability

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, announced that it has secured four new contracts in a successful start of 2023. Under the contracts, Knightscope will deploy three K5 Autonomous Security Robots (“ASRs”) and five K1 Blue Light Towers. The deployment locations include an existing Knightscope channel partner’s regional corporate office in Jacksonville, Florida, an Illinois-based casino, as well as the parking lot of an apartment complex for a well-known learning institution. A teaching hospital has also purchased five K1 Blue Light Towers to improve communications and safety on its New…

Continue Reading

MondayJan 09, 2023 10:26 am

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Status Update on Clinical Development Programs

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), is discussing upcoming priorities and near-term milestones regarding the status of its two clinical programs aimed at addressing multiple mental health conditions: CYB003 and CYB004. Designed for the treatment of Major Depressive Disorder (“MDD”), CYB003 is currently in a phase 1/2a clinical trial. CYB003 is a deuterated psilocybin analog. CYBN anticipates releasing an interim readout from the trial by the end of February 2023, which will provide an initial understanding of the safety and pharmacokinetic (“PK”) profile of the substance in humans. This interim data will…

Continue Reading

FridayJan 06, 2023 1:00 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Releases Projections for Double-Digit Revenue Growth in 2023

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process and providing its Fr8App platform for business-to-business, cross-border shipping in the USMCA region, has announced its 2023 guidance for revenue. According to the announcement, the company anticipates revenue this year to reach somewhere between $36 to $42 million; the company reported 2022 revenue of approximately $26 to $27 million.  “We look forward to continued growth in our cross-border and domestic FTL offerings over the course of the next 12 to 24 months and come into 2023 with a strong pipeline of existing customers…

Continue Reading

FridayJan 06, 2023 11:14 am

TinyGemsBreaks – Cepton Inc.’s (NASDAQ: CPTN) Vista-X120 Plus Featured in FreightWaves Article

Cepton (NASDAQ: CPTN), a Silicon Valley innovator of high-performance lidar solutions, was featured in a recent article published by FreightWaves. The piece, written by Jack Daleo and titled “Cepton unveils slimmed-down lidar solution,” discusses the Vista-X120 Plus, which offers easy integration at a height of 30 mm. “As the autonomous vehicle industry begins to gather steam, manufacturers of lidar — short for light detection and ranging — are trying to do more with less. Cepton (NASDAQ: CPTN), one of the few publicly traded lidar companies in the U.S., on Tuesday unveiled the Vista-X120 Plus, billed as ‘the world’s slimmest software…

Continue Reading

Contact us: (512) 354-7000